540788
ASPIRA
Start SIP
Invest Now
Start SIP in ASPIRA
Aspira Pathlab & Diagnostics live price: ₹56.35. It opened at ₹61 vs previous close ₹60; intraday high/low: ₹61/₹56. The 50 & 200 DMA stand at ₹61.30/₹62.31.
Aspira Pathlab & Diagnostics Performance
- Low
- ₹56
- High
- ₹61
- 52 Week Low
- ₹50
- 52 Week High
- ₹107
- Open Price₹61
- Previous Close₹60
- Volume607
- 50 DMA₹61.30
- 100 DMA₹62.43
- 200 DMA₹62.31
Investment Returns
- Over 1 Month -6.94%
- Over 3 Month -15.33%
- Over 6 Month -11.26%
- Over 1 Year -32.97%
Smart Investing Starts Here Start SIP with Aspira Pathlab & Diagnostics for Steady Growth!
Aspira Pathlab & Diagnostics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 39.5
- PEG Ratio
- 0.5
- Market Cap Cr
- 58
- P/B Ratio
- 4.5
- Average True Range
- 5.34
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -1.48
- RSI
- 50.55
- MFI
- 54.51
Aspira Pathlab & Diagnostics Financials
Aspira Pathlab & Diagnostics Technicals
EMA & SMA
Current Price
₹56.35
-3.81
(-6.33%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹59.19
- 50 Day
- ₹61.30
- 100 Day
- ₹62.43
- 200 Day
- ₹62.31
Resistance and Support
58.59
- R3 67.47
- R2 63.99
- R1 62.07
- S1 56.67
- S2 53.19
- S3 51.27
Aspira Pathlab & Diagnostics Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-10 | Quarterly Results | |
| 2025-11-12 | Quarterly Results | |
| 2025-08-12 | Quarterly Results | |
| 2025-05-16 | Audited Results | |
| 2025-02-07 | Quarterly Results |
Aspira Pathlab & Diagnostics F&O
About Aspira Pathlab & Diagnostics
- NSE Symbol
- ASPIRA
- BSE Symbol
- 540788
- Managing Director & CEO
- Dr. Pankaj J Shah
- ISIN
- INE500C01017
Similar Stocks to Aspira Pathlab & Diagnostics
Aspira Pathlab & Diagnostics FAQs
Aspira Pathlab & Diagnostics share price is ₹56 As on 16 March, 2026 | 17:32
The Market Cap of Aspira Pathlab & Diagnostics is ₹58 Cr As on 16 March, 2026 | 17:32
The P/E ratio of Aspira Pathlab & Diagnostics is 39.5 As on 16 March, 2026 | 17:32
The PB ratio of Aspira Pathlab & Diagnostics is 4.5 As on 16 March, 2026 | 17:32
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.